Revista Médica de Trujillo

Acknowledgement of peer reviewers

Jorge Omar Plasencia-Alvarez — 2024-12-31

Characteristics and level of satisfaction of parentes using pediatric teleconsultation during the Covid-19 pandemic

Jorge Ricardo García-Vinatea — 2024-12-31

Objetive: Determine the characteristics and level of satisfaction of parents using pediatric teleconsultation during the COVID-19 pandemic, treated at the Víctor Lazarte Echegaray The sample was made up of 273 parents to whom a user satisfaction survey was conducted by telephone, which consists of 15 questions that were answered based on the Thurstone scale. Results: the level of satisfaction was distributed as high (34.1%), medium (55.3%) and low (10.6%). Most of the patients belonged to the age group of 0-4 years (54.9%), male (54.2%) and resided in the province of Trujillo (67.8%). The parents were mainly aged between 30-39 years (45.8%), were female (90.5%) and had a higher level of education (60%). Teleconsultations had chronic diseases as the main reason for consultation (63.4%), lasted >10 minutes (76.9%), and prescriptions were issued in half of the cases (50.2%). Conclusion: The level of satisfaction of parents using pediatric teleconsultation was mainly at a medium-high level (79.4%). No association was found between the characteristics of the patient, the parent or the teleconsultation with the level of satisfaction.

Intelligence in data, scientific inference and artificial intelligence in medical statistics

Rodolfo Abanto — 2024-12-31

Evans syndrome and primary biliary cholangitis: A case report

Julio Enrique Carranza-Castillo — 2024-12-31

In this report, we present the case of a patient diagnosed with Evans syndrome and primary biliary cholangitis, an unusual combination that to date has few cases reported in the literature. The patient presented complex clinical characteristics, which, based on epidemiological data, was first diagnosed as dengue with alarm signs due to positive IgG results for this infection; he presented with fever, jaundice with direct predominance of hyperbilirubinemia, anemia, alkaline phosphatase and persistent elevated gamma-glutamyl transpeptidase; for which additional laboratory and imaging tests were performed to consolidate the etiology of the symptoms presented, to finally be diagnosed with both conditions.

Effects of curcumin on metabolic and systemic diseases: Narrative review

Wendy Fiorella Cruz-Bacilio — 2024-12-31

In recent years, the great role of nutrition on general health has been demonstrated, specifically, polyphenols in relation to the treatment of metabolic and systemic diseases. Curcumin, a substance extracted from turmeric and proposed as a treatment for various diseases due to its diverse properties. The bibliographic search was done in both Spanish and English with the keywords: "curcumin", "metabolic diseases", "systemic diseases" in Pubmed, Embase and Cochrane and Scholar Google. Curcumin is a polyphenol found in turmeric, which has been shown to have antioxidant, anti-inflammatory, hepatoprotective and antidiabetic properties. Its influence has been seen in metabolic syndrome, type 2 diabetes mellitus, lupus, rheumatoid arthritis and psoriasis. Conclusions: This narrative review summarizes the influence of curcumin supplementation on various pathologies, in addition to certain general aspects.

Anti-inflammatory protective effect of cannabidiol extracted from Cannabis sativa L. (hemp) against SARS-CoV-2 infection: A review of the literature

Victor Ludeña-Meléndez — 2024-12-31

Cannabidiol (CBD) is a non-psychotropic phytocannabinoid derived from cannabidiolic acid and has anti-inflammatory, analgesic, antineoplastic, and chemopreventive properties that even enhance the immune system thanks to the human endocannabinoid system. It is due to these characteristics that studies have been carried out to test its effectiveness as a treatment option against COVID-19, which meets the global medical goal of combating this disease since it became a pandemic in early 2020. CBD has been reported to have antiviral activity against the coronavirus, in addition to reducing the expression of the ACE-2 enzyme and the levels of proinflammatory cytokines, which results in structural and functional improvements of the tissues infected by SARS-CoV-2.

Preoperative physical training and its benefit on outcome in lung cancer surgery: Narrative review

Yusneht Grein Castrillon-Moscote — 2025-01-01

Lung cancer constitutes the main cause of years of life lost due to cancer, being one of the most frequent and the one that generates more deaths annually in the world. Physical training prior to surgery for this cancer has shown the potential to be beneficial for patients undergoing this type of intervention. However, the evidence is heterogeneous and inconclusive. Objective: To evaluate the most recent evidence on preoperative physical training and its benefit on outcomes in lung cancer surgery. Methods: Narrative literature review where PubMed, ScienceDirect, Web of Science, and MEDLINE databases were consulted. Results: Based on the most recent evidence and compared with standard care control groups, preoperative physical training may promote both functional and surgical postoperative outcomes, especially in terms of any complications, pulmonary or severe, as well as hospital stay, forced vital capacity, forced expiratory volume, and 6-minute walk distance. Although it does not impact mortality. However, the measurement of outcomes has been heterogeneous and the methodological quality of the studies ranges from very low to moderate. Conclusions: Although the evidence is limited and heterogeneous in the measurement of functional and postoperative outcomes of preoperative physical training over surgical intervention with curative intent for lung cancer, there is a trend in favor of the latter, especially in terms of lower frequency of postoperative pulmonary complications and shorter hospital stay.

Characteristics of social security health workers – La Libertad, with Covid-19 at the end of the fifth wave

Lester Byron Rodríguez-Lázaro — 2024-12-31